You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome

Article info

Article menu

Download PDFPDF

Dialogue
Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome

Authors

  • Bonnie Bermas Division of Rheumatic Diseases, UT Southwestern Medical, Dallas, Texas, USA PubMed articlesGoogle scholar articles
  • Nathalie Costedoat-Chalumeau Service de médecine interne, Centre de référence maladies autoimmunes et systémiques rares Île de France, APHP, Hopital Cochin, Paris, FranceUniversité de Paris, Centre de recherche épidémiologie et biostatistiques de Sorbonne Paris Cité, F-75004 Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Bonnie Bermas; Bonnie.Bermas{at}UTSouthwestern.edu
View Full Text

Citation

Bermas B, Costedoat-Chalumeau N
Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
Lupus Science & Medicine 2022;9:e000630. doi: 10.1136/lupus-2021-000630

Publication history

  • Received December 22, 2021
  • Accepted December 23, 2021
  • First published January 7, 2022.
Online issue publication 
May 08, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.